Kolon TissueGene (XKRX:950160) Other Income (Expense) : ₩-12,852 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Kolon TissueGene Other Income (Expense)?

Kolon TissueGene's other income expense for the Kolon TissueGene's pretax income for the three months ended in Dec. 2024 was ₩-12,884 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-12,852 Mil.

Kolon TissueGene Other Income (Expense) Historical Data

The historical data trend for Kolon TissueGene's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kolon TissueGene Other Income (Expense) Chart

Kolon TissueGene Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-149.77

88.38

6,183.16

1,598.00

-12,847.25

Kolon TissueGene Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Other Income (Expense)	Get a 7-Day Free Trial															1,151.95	279.50	-180.47	-67.26	-12,883.72

Kolon TissueGene Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-12,852 Mil.

Kolon TissueGene (XKRX:950160) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Kolon TissueGene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kolon TissueGene Inc (XKRX:950160) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

9713 Key West Avenue, Suite 300, Rockville, MD, USA, 20850

Website

https://www.tissuegene.com

Kolon TissueGene Inc is a biopharmaceutical company that develops regenerative therapies for the treatment of various orthopedic disorders. It is developing four product candidates, TG-C, TG-B, TG-D and TG-N for regeneration of cartilage, bone, disc and nerve.

Kolon TissueGene Headlines

No Headlines